Morbidity and mortality results from a prospective randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage II and III lower rectal cancer: Japan Clinical Oncology Group study JCOG0212.
S. Fujita(Tochigi Cancer Center), Yoshihisa Saida(Toho University Ohashi Medical Center), Tomoaki Aoki, Yukihide Kanemitsu(National Cancer Center), Junki Mizusawa(Japan Clinical Cancer Research Organization), Yusuke Kinugasa(The Japanese Society of Gastroenterological Surgery), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Manabu Shiozawa(Kanagawa Prefectural Hospital Organization), S. Saito(Tokuyama (Japan)), Yoshihiro Akazai(Okayama Saiseikai General Hospital), Kazuo Shirouzu(Japan Community Healthcare Organization), Keiichiro Nakamura, Hiroyuki Bandou, Shoichi Fujii, K. Murata, Yoshihiro Moriya(Cube Technology (United States)), Masayuki Ohue, Nobuhiro Takiguchi(Chiba Cancer Center), Naoyasu Saito
Cited by 2
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600